Singapore markets close in 6 hours 49 minutes

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1985-0.0266 (-11.82%)
At close: 04:00PM EDT
0.2051 +0.01 (+3.32%)
After hours: 07:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 33.76M
Enterprise value 25.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)42.31
Price/book (mrq)4.79
Enterprise value/revenue 31.96
Enterprise value/EBITDA -0.85

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 3-80.77%
S&P500 52-week change 3-16.62%
52-week high 31.4800
52-week low 30.1800
50-day moving average 30.3322
200-day moving average 30.4836

Share statistics

Avg vol (3-month) 3699.41k
Avg vol (10-day) 31.32M
Shares outstanding 5149.98M
Implied shares outstanding 6N/A
Float 8148.54M
% held by insiders 11.07%
% held by institutions 18.65%
Shares short (14 Sept 2022) 43.66M
Short ratio (14 Sept 2022) 48.96
Short % of float (14 Sept 2022) 42.45%
Short % of shares outstanding (14 Sept 2022) 42.44%
Shares short (prior month 14 Aug 2022) 44.68M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 312 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,305.80%

Management effectiveness

Return on assets (ttm)-52.56%
Return on equity (ttm)-117.30%

Income statement

Revenue (ttm)794.89k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-96.90%
Gross profit (ttm)-4.66M
EBITDA -32.77M
Net income avi to common (ttm)-31.51M
Diluted EPS (ttm)-0.2730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.88M
Total cash per share (mrq)0.06
Total debt (mrq)1.12M
Total debt/equity (mrq)15.92
Current ratio (mrq)1.58
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-33.25M
Levered free cash flow (ttm)-20.2M